The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia

Published:2017-04-25 Issue:2 Volume:178 Page:302-307
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Arnold Donald M.¹²³,Vrbensky John R.¹,Karim Nadia¹,Smith James W.¹,Liu Yang¹²,Ivetic Nikola⁴,Kelton John G.¹²,Nazy Ishac¹²^ORCID

Affiliation:

1. Department of Medicine; Michael G. DeGroote School of Medicine; McMaster University; Hamilton Ontario Canada

2. McMaster Centre for Transfusion Research; Hamilton Ontario Canada

3. Canadian Blood Services; Hamilton Ontario Canada

4. Department of Biochemistry and Biomedical Sciences; McMaster University; Hamilton Ontario Canada

Funder

Canadian Institutes of Health Research

Canadian Blood Services

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14664/fullpdf

Reference35 articles.

1. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies;Aledort;American Journal of Hematology,2004

2. Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia;Arnold;Journal of Thrombosis and Haemostasis,2012a

3. A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia;Arnold;Blood,2012b

4. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura;Arnold;Annals of Internal Medicine,2007

5. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro;Bouaziz;European Journal of Immunology,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment;Blood Reviews;2024-09

2. Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study;The Lancet Regional Health - Western Pacific;2024-06

3. Clinical efficacy of anti-CD20 antibodies in autoimmune diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Anti-GPIb/IX autoantibodies are associated with poor response to dexamethasone combined with rituximab therapy in primary immune thrombocytopenia patients;Platelets;2023-09-18

5. Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis;Doklady Biochemistry and Biophysics;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3